References and Notes
1a
Guanidines:
Historical, Biological, Biochemical and Clinical Aspects of the
Naturally Occurring Guanidino Compounds
Mori A.
Cohen BD.
Lowenthal A.
Plenum Press;
New York:
1985.
1b
Guanidines 2: Further Explorations
of the Biological and Clinical Significance of Guanidino Compounds
Mori A.
Cohen BD.
Koide H.
Plenum
Press;
New York:
1987.
1c
Feichtier K.
Sings HL.
Baker TJ.
Matthews K.
Goodman M.
J.
Org. Chem.
1998,
63:
8432
1d
Le V.-D.
Wong C.-H.
J. Org. Chem.
2000,
65:
2399
1e
McAlpine IJ.
Armstrong RW.
Tetrahedron
Lett.
2000,
41:
1849
1f
De Clercq E.
Nat.
Rev. Drug Discovery
2006,
5:
1015
2a
Petersen MJ.
Nielsen CK.
Arrigoni-Martelli E.
J.
Med. Chem.
1978,
21:
773
2b
Ganelin CR.
Chronicles of Drug Discovery
Vol.
1:
Bindra JS.
Lednicer D.
Wiley;
New
York:
1982.
p.1-38
2c
Taniguchi K.
Shigenaga S.
Ogahara T.
Fujitsu T.
Matsno M.
Chem. Pharm.
Bull.
1993,
41:
301
2d
Yoshiizumi K.
Seko N.
Nishimura N.
Ikeda S.
Yoshino K.
Kondo H.
Tanizawa K.
Bioorg.
Med. Chem. Lett.
1998,
8:
3397
3a
Heys L.
Moore CG.
Murphy PJ.
Chem. Soc. Rev.
2000,
29:
57 ; and references cited there
3b
Schug KA.
Lindner W.
Chem. Rev.
2005,
105:
67
4a
Cotton FA.
Day VW.
Hazen EE.
Larsen S.
J. Am. Chem. Soc.
1973,
95:
4834
4b
Schneider SE.
Bishop PA.
Salazar MA.
Bishop OA.
Anslyn EV.
Tetrahedron
1998,
54:
15063
4c
Linton B.
Hamilton
AD.
Tetrahedron
1999,
55:
6027
4d
Linton BR.
Carr AJ.
Orner BP.
Hamilton AD.
J.
Org. Chem.
2000,
65:
1566
5a
Orner BP.
Hamilton AD.
J. Inclusion Phenom. Macrocyclic Chem.
2001,
41:
141
5b
Manimala JC.
Anslyn EV.
Eur.
J. Org. Chem.
2002,
3909
5c
Katritzky AR.
Rogovoy BV.
ARKIVOC
2005,
(iv):
49
5d
Ohara K.
Vasseur J.-J.
Smietana M.
Tetrahedron
Lett.
2009,
50:
1463
6
Schow S.
Cyanamide, In Encyclopedia
of Reagents for Organic Synthesis
Paquette LA.
Wiley;
Sussex:
1996.
p.1408-1410
7a
Bernatowicz MS.
Wu Y.
Matsueda GR.
J. Org. Chem.
1992,
57:
2497
7b
Drake B.
Patek M.
Lebl M.
Synthesis
1994,
579
7c
Patek M.
Smrcina M.
Nakanishi E.
Izawa H.
J. Comb. Chem.
2000,
2:
370
7d
Drager G.
Solodenko W.
Messinger J.
Schön U.
Kirschning A.
Tetrahedron
Lett.
2002,
43:
1401
7e
Castillo-Melendez
JA.
Golding BT.
Synthesis
2004,
1655
7f
Solodenko W.
Bröker P.
Messinger J.
Schön U.
Kirschning A.
Synthesis
2006,
461
8
Palmer DC.
O-Methylisourea, In Encyclopedia
of Reagents for Organic Synthesis
Paquette LA.
Wiley;
Sussex:
1995.
p.3525-3526
9
Feichtinger K.
Zapf C.
Sings HL.
Goodman M.
J. Org. Chem.
1998,
63:
3804
10a
Levallet C.
Lerpiniere J.
Ko SY.
Tetrahedron
1997,
53:
5291
10b
Guo ZX.
Cammidge AN.
Horwell DC.
Synth. Commun.
2000,
30:
2933
10c
Gers T.
Kunce D.
Markowski P.
Izdebski J.
Synthesis
2004,
37
11
Yong YF.
Kowalski JA.
Lipton MA.
J. Org. Chem.
1997,
62:
1540
12 Many of these reagents present difficulties
such as toxicity, odour, moisture-sensitivity, harsh reaction conditions,
and long reaction time.
13 The application of reagents containing
two urethane-type protecting groups is beneficial since two electron-withdrawing
groups in positions conjugated with the reaction center increase
the electrophilicity and the solubility of the guanylating agent.
14
Porcheddu A.
Giacomelli G.
Piredda I.
J.
Comb. Chem.
2009,
11:
126
15
Porcheddu A.
Giacomelli G.
Chighine A.
Masala S.
Org. Lett.
2004,
6:
4925
16a
Falorni M.
Porcheddu A.
Taddei M.
Tetrahedron Lett.
1999,
40:
4395
16b
Blotny G.
Tetrahedron
2006,
62:
9507 ; and references cited therein
16c
Giacomelli G.
Porcheddu A.
1,3,5-Triazines, In Comprehensive Heterocyclic Chemistry III
Vol.
9:
Katritzky AR.
Ramsden CA.
Scriven EFV.
Taylor RJK.
Elsevier;
Oxford:
2008.
p.197-290
17 Generally, the conversion of protected
thiourea into a guanidine requires initial activation.
18 In particularly, we were interested
in replacing the traditional activating Mukaiyama reagent with the
readily available cyanuric chloride for the guanylation of di-Boc-protected
thiourea.
19 The use of NMM or Et3N
proved to be crucial to reaction success. Without a base, the reaction
did not take place.
20 Adding a catalytic amount of DMAP
we have detected an increased reaction rate.
21 The Boc protecting group was then
removed by treatment with 3 M anhyd methanolic HCl, to yield the
guanidine as the HCl salt in 96% isolated yield.
22 The ability to use only 0.33 equiv
of the TCT as guanylating agent is advantageous since it minimizes
reagent consumption and byproduct generation compared to the Mukaiyama
reagent and S-methylisothioureas derivatives. Moreover
our method does not give off toxic gaseous side product such as
methyl mercaptan that is generated using N,N′′-bis-Boc-S-methylisotiourea as guanylating reagent (see
ref. 10a-c).
23
Representative
Procedure for the Synthesis of N
,
N
′′-Di-Boc-protected
Guanidines: N
,
N
′-Bis(
tert
-butoxy-carbonyl)-
N
′′-benzylguanidine (3a)
To a solution of cyanuric
chloride (185 mg, 1.0 mmol) in dry THF (20 mL), N-methylmorpholine
(303 mg, 330 µL, 3.0 mmol) was added at 0 ˚C
under argon and with vigorous stirring. A white suspension was formed
to which a solution of the N,N′-di-Boc-thiourea 1 (830 mg,
3.0 mmol) and N-methylmorpholine (606
mg, 660 µL) in anhydrous THF (20 mL) was added, and the
stirring was continued at reflux temperature for 12 h. The slurry
was cooled to r.t. and to this mixture, benzylamine 2a (482
mg, 491 µL, 4.5 mmol) and DMAP (10 mg) were added, and
the stirring was run for additional 8 h at r.t. The reaction was
judged to be complete by TLC analysis. After completion of the reaction,
solid material was collected by suction, followed by successive washing
with a minimal amount of THF, and the filtrates were combined and
concentrated. The residue was dissolved in CH2Cl2,
and the resulting solution was washed successively with H2O,
HCl (1 N), NaHCO3 (sat. solution), and then with brine.
The organic layer was dried over anhyd Na2SO4,
passed through short a silica gel column (hexane-EtOAc = 8:2),
and the solvent removed under reduced pressure to give 3a (1.0 g, 95%) pure as an off-white
solid; mp 125-126 ˚C [lit.:7b mp
126-127 ˚C]. TLC: R
f
= 0.46 (hexane-EtOAc = 8:2). ¹H
NMR (300 MHz, CDCl3): δ = 1.47 (s,
9 H), 1.51 (s, 9 H), 4.59 (d, J = 5.2
Hz, 2 H), 7.20-7.39 (m, 5 H), 8.43 (br s, 1 H), 11.41 (br
s, 1 H). ¹³C NMR (75 MHz, CDCl3): δ = 27.9,
28.3, 44.9, 80.5, 82.9, 127.8, 128.2, 129.0, 137.2, 152.9, 156.4,
163.4. ESI-HRMS: m/z [M + H]+ calcd
for C18H28N3O4: 350.2080;
found: 350.2092. Anal. Calcd for C18H27N3O4:
C, 61,87; H, 7,79; N, 12,03. Found: C, 61.71; H, 7.95, N, 11.92.
24 The triazine ring is weakly basic
therefore a dilute acid wash is able to remove any byproduct as
well as any excess reagent from the reaction mixture. Reagents
for High-Throughput Solid-Phase Organic Synthesis, In Handbook of Reagents for Organic Synthesis
Wipf P.
Wiley;
Sussex:
1999.
p.72-74
25 Performing the model reaction in CH2Cl2 we
have recovered the desired protected guanidine 3a in
very low yields (<5%).
26 TCT react DMF to give an insoluble
Vilsmeier-Haack-type specie, which precipitates: De
Luca L.
Giacomelli G.
Porcheddu A.
Org. Lett.
2002,
4:
553 ; under these conditions, we observed a partial
removal of Boc-protective group, and the formation of several side
products in the crude reaction mixture.
27 Unchanged reagents were present still
after 36 h at r.t.
28 All the analytical data are consistent
with those described in the literature.
29 Identified by matching all the analytical
data with those described in literature, see: Balakrishnan S.
Zhao C.
Zondlo NJ.
J. Org. Chem.
2007,
72:
9834
30 In the reaction of TCT/di-Boc-thiourea 1 with phenylalanine methyl esther 2o, we have not observed significant racemization
of the stereogenic center as revealed by the optical rotation value
of the products 3o if compared with that
reported in the literature (ref. 29).
31a
Ho K.-C.
Sun C.
Bioorg.
Med. Chem. Lett.
1999,
9:
1517
31b See also ref. 5c.
32 The exact intermediates for this TCT-promoted
guanylating reaction formation are unknown.